abstract |
(57) [Summary] The present invention relates to compounds which are inhibitors of the interleukin-1β converting enzyme of formula (I). The present invention also provides a method of treating stroke, inflammatory disease, reperfusion injury, Alzheimer's disease and bacillary dysentery, and a pharmaceutically acceptable composition comprising a compound that is an inhibitor of interleukin-1β converting enzyme. About. |